Latest News about FDMT
Recent news which mentions FDMT
Eye Disease Focused 4D Molecular Therapeutics Lays Out 52-Week Results From Wet AMD Study
February 10, 2025
From Benzinga
What 5 Analyst Ratings Have To Say About 4D Molecular Therapeutics
December 18, 2024
Tickers
FDMT
From Benzinga
From Benzinga
Analyst Expectations For 4D Molecular Therapeutics's Future
November 14, 2024
Tickers
FDMT
From Benzinga
4D Molecular Therapeutics Stock Falls After Follow-Up Data From Mid-Stage Study Of Vision Loss Drug Candidate
September 19, 2024
From Benzinga
The Latest Analyst Ratings For 4D Molecular Therapeutics
September 09, 2024
Tickers
FDMT
From Benzinga
Tickers
FDMT
From InvestorPlace
Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
July 18, 2024
From Benzinga
4D Molecular Therapeutics Goes Neck To Neck With Rival, Shares New Phase 2 Data For Its Wet AMD Candidate
July 17, 2024
From Benzinga
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 17, 2024
From Benzinga
Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside
June 07, 2024
From Benzinga
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 06, 2024
From Benzinga
Why Is 4D Molecular Therapeutics Stock Trading Lower On Thursday? Genetic Disease-Focused Study Data Released
June 06, 2024
From Benzinga
From Benzinga
Tickers
FDMT
From InvestorPlace
To The Moon! A Look Inside An ETF Focused On Companies At The Cutting Edge Of Innovation
April 18, 2024
From Benzinga
4D Molecular Therapeutics Outlines Pivotal Development Plans For Cystic Fibrosis, Rare Inherited Disease
March 28, 2024
From Benzinga
From Benzinga
Why 4D Molecular Therapeutics (FDMT) Stock Is Diving
February 07, 2024
From Benzinga
What 4 Analyst Ratings Have To Say About 4D Molecular Therapeutics
February 07, 2024
Tickers
FDMT
From Benzinga
4D Molecular Therapeutics' 4D-150 Phase 2 Data Met Investor Expectations, Analyst Boosts Forecast
February 06, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.